CT SB00186

Defines and establishes framework for collaborative drug therapy management agreements and policies between qualified pharmacists and prescribing practitioners (physicians or advanced practice registered nurses) to manage individual patient or population drug therapy.

Requires a provider-patient relationship to exist before collaborative drug therapy management begins, established through medical complaint, medical history, physical examination, and a logical connection between these elements and prescribed drugs.

Authorizes qualified pharmacists to initiate, modify, continue, discontinue, or deprescribe drug therapy; order laboratory tests; and administer drugs according to written protocols or collaborative drug therapy care plans, with notification to prescribing practitioners within 24 hours when discontinuing or deprescribing.

Requires qualified pharmacists to demonstrate competence by reviewing the latest "Pharmacists' Patient Care Process" published by the Joint Commission of Pharmacy Practitioners and complying with regulations adopted by the Commissioner of Consumer Protection in consultation with the Commissioner of Public Health.

Applies collaborative drug therapy management framework to nursing home facilities' prescription drug formulary systems, requiring medical directors to notify prescribing practitioners before substituting prescribed drugs and prohibiting substitution if the practitioner objects.